This one comes in on the wrong side of the weekend, but it’s worth some attention to people who follow the media and follow financial news: The Pittsburgh Post-Gazette sued pharmaceutical company Mylan on Friday — that action itself a countersuit to Mylan’s lawsuit against the paper. (Read the documents for yourself at this blog.)
Mylan Inc’s subsidiary Mylan Pharmaceuticals sued the Post-Gazette and two of its journalists in August, claiming that the daily paper and its reporters improperly obtained confidential documents and misappropriated trade secrets in the process of reporting and publishing a story on an internal company report about potential problems at Mylan’s Morgantown, West Virginia, plant. Mylan’s internal report, as the Post-Gazette reported, showed that employees had overridden computer-generated warnings about possible problems in its drug-making process.
Mylan naturally wasn’t crazy about that, prompting the lawsuit. Now, the Post-Gazette is smacking back. Here is an excerpt from its own news story:
In one filing, attorneys for the newspaper said that all of the documents used in the July 26 story were obtained lawfully.
“In sum, the Post-Gazette did nothing wrong whatsoever — not in obtaining information for publication and not in publishing.”
